2022
DOI: 10.1186/s40580-022-00310-0
|View full text |Cite
|
Sign up to set email alerts
|

Nanotechnology-enabled immunoengineering approaches to advance therapeutic applications

Abstract: Immunotherapy has reached clinical success in the last decade, with the emergence of new and effective treatments such as checkpoint blockade therapy and CAR T-cell therapy that have drastically improved patient outcomes. Still, these therapies can be improved to limit off-target effects, mitigate systemic toxicities, and increase overall efficacies. Nanoscale engineering offers strategies that enable researchers to attain these goals through the manipulation of immune cell functions, such as enhancing immunit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 22 publications
(11 citation statements)
references
References 231 publications
(210 reference statements)
0
10
0
Order By: Relevance
“…These medications have shown a sharp rise in clinical use since their first approval in 2011 for metastatic melanoma. 18 Immune checkpoints are receptors expressed on cells of the immune system; they allow for the dynamic regulation of immune homeostasis and play an important role in T cell activity. Programmed cell death protein 1 (PD-1) and PD-1 ligand (PD-L1) are immune checkpoint proteins expressed on T lymphocytes, tumor cells, and myeloid cells that have invaded tumors.…”
Section: Where Do We Stand In Cancer Immunotherapeutics?mentioning
confidence: 99%
“…These medications have shown a sharp rise in clinical use since their first approval in 2011 for metastatic melanoma. 18 Immune checkpoints are receptors expressed on cells of the immune system; they allow for the dynamic regulation of immune homeostasis and play an important role in T cell activity. Programmed cell death protein 1 (PD-1) and PD-1 ligand (PD-L1) are immune checkpoint proteins expressed on T lymphocytes, tumor cells, and myeloid cells that have invaded tumors.…”
Section: Where Do We Stand In Cancer Immunotherapeutics?mentioning
confidence: 99%
“…In turn, immune cells are stimulated by proinflammatory cytokines, leading to immune dysregulation in patients. Nanomaterials are widely studied in biology and medicine due to their excellent chemical and physical properties, such as intervening in the expression and signaling pathways of immune cells through their intrinsic properties or loaded drugs 171 , 172 , 173 . Therefore, the introduction of NPs to target immune cells may be another inspired strategy for COVID-19 174 , 175 , such as the most important macrophages and neutrophils involved in the immune response activated by SARS-CoV-2.…”
Section: Nanotechnology-related Strategies Ameliorate Covid-19mentioning
confidence: 99%
“…Aptamer sensors based on various new biomaterials have been developed. For example, an aptamer sensor based on a gold material can be freely immobilised using various chemical conjugations [ 39 , 40 , 41 , 42 , 43 ]. In addition, gold has active electron-transfer effect and can amplify the electrochemical signal by the folding of methylene blue conjugated aptamers [ 44 , 45 , 46 ].…”
Section: Introductionmentioning
confidence: 99%